PDUFA VI: FDA Proposes Expanding Sentinel, Real-World Safety Data Sources
This article was originally published in The Pink Sheet Daily
Growth of post-market surveillance system also may require more resources.
You may also be interested in...
New ‘Guardian’ program to monitor post-market effectiveness through the Sentinel electronic data network will take five years to build, FDA’s Woodcock says.
FDA Commissioner nominee outlines ideas for improving clinical trials in written responses to senators' questions; HELP Committee to vote Jan. 12.
Advocates counter FDA’s problems with Duchenne muscular dystrophy treatment's trial data using real-life experience.